Senate Drug Pricing Legislation Headed Toward Mid-September Committee Markup
Executive Summary
Republican Finance Committee staffer thinks drug pricing legislation will leave most negotiation details up to HHS and try to avoid impact on commercial market.
You may also be interested in...
Pharma On Its Back Foot As US Drug Price Reform Advances
Big pharma leaders warn of steep cuts to R&D and US jobs if US drug pricing reform legislation paves the way for direct government price negotiations.
Pharma On Its Back Foot As US Drug Price Reform Advances
Big pharma leaders warn of steep cuts to R&D and US jobs if US drug pricing reform legislation paves the way for direct government price negotiations.
US Employers Say Government Drug Pricing Reforms Needed To Supplement Market-Based Efforts
Annual Business Group on Health survey on employer-sponsored insurance covers pricing reform, rebate model alternatives, paying for high-cost drugs and copay coupons.